Metallothioneins and cancer

Current Protein and Peptide Science

Volumn 10, Issue 4, 2009, Pages 360-375

  Eckschlager, Tomas ^a   Adam, Vojtech ^b   Hrabeta, Jan ^a   Figova, Katarina ^a   Kizek, Rene ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MENDEL UNIVERSITY IN BRNO   (Czech Republic)

Author keywords

Cancer cell chemoresistance; Cancer marker; Detection; Metallothioneins

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; EPTAPLATIN; FLUOROURACIL; IRINOTECAN; METALLOTHIONEIN; REACTIVE OXYGEN METABOLITE; TUMOR MARKER; ZINC;

BLADDER CARCINOMA; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; DRUG RESPONSE; ENDOMETRIUM TUMOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; KIDNEY CARCINOMA; LARYNX CANCER; LUNG CANCER; MELANOMA; MOUTH TUMOR; NEOPLASM; NEUROPROTECTION; NONHUMAN; OVARY TUMOR; OXIDATION REDUCTION STATE; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CYTOSTATIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; METALLOTHIONEIN; NEOPLASMS;

EID: 63849266586     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920309788922243     Document Type: Review

References (235)

1. Miles, A. T.; Hawksworth, G. M.; Beattie, J. H.; Rodilla, V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol., 2000, 35, 35-70.
2. Simpkins, C. O. Metallothionein in human disease. Cell. Mol. Biol., 2000, 46, 465-488.
3. Ghoshal, K.; Jacob, S. T. Regulation of metallothionein gene expression. Prog. Nucleic Acid Res. Mol. Biol., 2001, 66, 357-384.
4. Olesen, C.; Moller, M.; Byskov, A. G. Tesmin transcription is regulated differently during male and female meiosis. Mol. Reprod. Dev., 2004, 67, 116-126.
5. Kagi, J. H. R.; Schaffer, A. Biochemistry of Metallothionein. Biochemistry, 1988, 27, 8509-8515.
6. Aschner, M.; Syversen, T.; Souza, D. O.; Rocha, J. B. T. Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Exp. Biol. Med., 2006, 231, 1468-1473.
7. Davis, S. R.; Cousins, R. J. Metallothionein expression in animals: a physiological perspective on function. J. Nutr., 2000, 130, 1085-1088.
8. Sato, M.; Kondoh, M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med., 2002, 196, 9-22.
9. Nagel, W. W.; Vallee, B. L. Cell-cycle regulation of metallothionein in human colonic-cancer cells. Proc. Natl. Acad. Sci. USA, 1995, 92, 579-583.
10. Cherian, M. G.; Apostolova, M. D. Nuclear localization of metallothionein during cell proliferation and differentiation. Cell. Mol. Biol., 2000, 46, 347-356.
11. Trayhurn, P.; Duncan, J. S.; Wood, A. M.; Beattie, J. H. Metallothionein gene expression and secretion in white adipose tissue. Am. J. Physiol.-Regul. Integr. Comp. Physiol., 2000, 279, R2329-R2335.
12. Jin, R. X.; Chow, V. T. K.; Tan, P. H.; Dheen, S. T.; Duan, W.; Day, B. H. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis, 2002, 23, 81-86.
13. Karin, M.; Eddy, R. L.; Henry, W. M.; Haley, L. L.; Byers, M. G.; Shows, T. B. Human metallothionein genes are clustered an chromosome-16. Proc. Natl. Acad. Sci. USA, 1984, 81, 5494-5498.
14. Gunes, C., Heuchel, R.; Georgiev, O.; Muller, K. H.; Lichtlen, P.; Bluthmann, H.; Marino, S.; Aguzzi, A.; Schaffner, W. Embryonic lethality and liver degeneration in mice lacking the metalresponsive transcriptional activator MTF-1. EMBO J., 1998, 17, 2846-2854.
15. Klassen, R. B.; Crenshaw, K.; Kozyraki, R.; Verroust, P. J.; Tio, L.; Atrian, S.; Allen, P. L.; Hammond, T. G. Megalin mediates renal uptake of heavy metal metallothionein complexes. Am. J. Physiol.-Ren. Physiol., 2004, 287, F393-F403.
16. Culotta, V. C.; Hamer, D. H. Fine mapping of a mouse metallothionein gene metal response element. Mol. Cell. Biol., 1989, 9, 1376-1380.
17. Searle, P. F.; Stuart, G. W.; Palmiter, R. D. Building a metalresponsive promoter with synthetic regulatory elements. Mol. Cell. Biol., 1985, 5, 1480-1489.
18. Baird, S. K.; Kurz, T.; Brunk, U. T. Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem. J., 2006, 394, 275-283.
19. Nath, R.; Kambadur, R.; Gulati, S.; Paliwal, V. K.; Sharma, M. Molecular aspects, physiological-function, and clinical-significance of metallothioneins. Crc Crit. Rev. Food Sci. Nutr., 1988, 27, 41-85.
20. Nordberg, M.; Nordberg, G. F. Toxicological aspects of metallothionein. Cell. Mol. Biol., 2000, 46, 451-463.
21. Siddik, Z. H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 2003, 22, 7265-7279.
22. Ye, B.; Maret, W.; Vallee, B. L. Zinc metallothionein imported into liver mitochondria modulates respiration. Proc. Natl. Acad. Sci. USA, 2001, 98, 2317-2322.
23. Zhang, B. L.; Sun, W. Y.; Tang, W. X. Determination of the association constant of platinum(II) to metallothionein. J. Inorg. Biochem., 1997, 65, 295-298.
24. Knipp, M.; Karotki, A. V.; Chesnov, S.; Natile, G.; Sadler, P. J.; Brabec, V.; Vasak, M. Reaction of Zn(7)Metallothionein with cis- and trans-[Pt(N-donor)(2)CI-2] anticancer complexes: trans-Pt-II complexes retain their N-donor ligands. J. Med. Chem., 2007, 50, 4075-4086.
25. Krizkova, S.; Adam, V.; Petrlova, J.; Zitka, O.; Stejskal, K.; Zehnalek, J.; Sures, B.; Tmkova, L.; Beklova, M.; Kizek, R. A suggestion of electrochemical biosensor for study of platinum(II)-DNA interactions. Electroanalysis, 2007, 19, 331-338.
26. Petrlova, J.; Potesil, D.; Zehnalek, J.; Sores, B.; Adam, V.; Trnkova, L.; Kizek, R. Cisplatin electrochemical biosensor. Electrochim. Acta, 2006, 51, 5169-5173.
27. Bataineh, Z. M.; Nusier, M. K. Metallothionein expression in human prostate gland. Saudi Med. J., 2003, 24, 1246-1249.
28. Ejnik, J.; Munoz, A.; Gan, T.; Shaw, C. F.; Petering, D. H. Interprotein metal ion exchange between cadmium-carbonic anhydrase and apo- or zinc-metallothionein. J. Biol. Inorg. Chem., 1999, 4, 784-790.
29. Zeng, J.; Heuchel, R.; Schaffner, W.; Kagi, J. H. R. Thionein (Apometallothionein) can modulate DNA-binding and transcription activation by zinc finger containing factor-Sp1. FEBS Lett., 1991, 279, 310-312.
30. Taylor, K. M.; Morgan, H. E.; Smart, K.; Zahari, N. M.; Pumford, S,; Ellis, I. O.; Robertson, J. F. R.; Nicholson, R. I. The emerging role of the LrV-1 subfamily of zinc transporters in breast cancer. Mol. Med., 2007, 13, 396-406.
31. Daniel, K. G.; Harbach, R. H.; Guida, W. C.; Don, Q. P. Copper storage diseases: Menkes, Wilson's, and cancer. Front. Biosci., 2004, 9, 2652-2662.
32. Cousins, R. J. Absorption, transport, and hepatic-metabolism of copper and zinc - special reference to metallothionein and ceruloplasmin. Physiol. Rev., 1985, 65, 238-309.
33. Butcher, H. L.; Kennette, W. A.; Collins, O.; Zalups, R. K.; Koropatnick, J. Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts. J. Pharmacol. Exp. Ther., 2004, 310, 589-598.
34. Kim, C. H.; Kim, J. H.; Lee, J.; Ahn, Y. S. Zinc-induced NF-kappa B inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol. Appl. Pharmacol., 2003, 190, 189-196.
35. Abdel-Mageed, A. B.; Agrawal, K. C. Activation of nuclear factor kappa B: potential role in metallothionein-mediated mitogenic response. Cancer Res., 1998, 58, 2335-2338.
36. Wang, C. Y.; Cusack, J. C.; Liu, R.; Baldwin, A. S. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappa B. Nat. Med., 1999, 5, 412-417.
37. Knipp, M.; Meloni, G.; Roschitzki, B.; Vasak, M. Zn(7) metallothionein-3 and the synaptic vesicle cycle: interaction of metallothionein-3 with the small GTPase Rab3A. Biochemistry, 2005, 44, 3159-3165.
38. Ostrakhovitch, E. A.; Olsson, P. E.; Jiang, S.; Cherian, M. G. Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett., 2006, 580, 1235-1238.
39. Ostrakhovitch, E. A.; Olsson, P. E.; von Hofsten, J.; Cherian, M. G. P53 mediated regulation of metallothionein transcription in breast cancer cells. J. Cell. Biochem., 2007, DOI No.: 10.1002/ jcb.21381.
40. Murray, R. K.; Granner, D. K.; Mayes, P. A.; Rodwell, V. W. Harper's Illustrated Biochemistry, Lange Medical Books/McGraw-Hill Medical Publishing Division: New York, 2003.
41. Maret, W.; Vallee, B. L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad Sci. USA, 1998, 95, 3478-3482.
42. Hanada, K.; Sawamura, D.; Tamai, K.; Baba, T.; Hashimoto, I.; Muramatsu, T.; Miura, N.; Naganuma, A. Novel function of metallothionein in photoprotection: metallothionein-null mouse exhibits reduced tolerance against ultraviolet B injury in the skin. J. Invest. Dermatol., 1998, 111, 582-585.
43. Hansen, C.; Ablett, E.; Green, A.; Sturm, R. A.; Dunn, I.S.; Fairlie, D. P.; West, M. L.; Parsons, P. G. Biphasic response of the metallothionein promoter to ultraviolet radiation in human melanoma cells. Photochem. Photobiol., 1997, 65, 550-555.
44. Reeve, V. E.; Nishimura, N.; Bosnic, M.; Michalska, A. E.; Choo, K. H. A. Lack of metallothionein-I and -II exacerbates the immunosuppressive effect of ultraviolet B radiation and cis-urocanic acid in mice. Immunology, 2000, 100, 399-404.
45. Hishikawa, Y.; Abe, S.; Kinugasa, S.; Yoshimura, H.; Monden, N.; Igarashi, M.; Tachibana, M.; Nagasue, N. Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. Oncology, 1997, 54, 342-347.
46. Chin, J. L.; Banerhee, D.; Kadhim, S. A.; Kontozoglou, T. E.; Chauvin, P. J.; Cherian, M. G. Metallothionein in testicular germ-cell tumors and drug-resistance - clinical correlation. Cancer, 1993, 72, 3029-3035.
47. Okazaki, Y.; Miura, N.; Satoh, M.; Imura, N.; Naganuma, A. Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice. Biochem. Biophys. Res. Commun., 1998, 245, 815-818.
48. Sunada, F.; Itabashi, M.; Ohkura, H.; Okumura, T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World.J. Gastroenterol., 2005, 11, 5696-5700.
49. Tsangaris, G. T.; Tzortzatou-Stadiopoulou, F. Metallothionein expression prevents apoptosis: a study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line. Anti-cancer Res., 1998, 18, 2423-2433.
50. Andrews, G. K.; Geiser, J. Expression of the mouse metallothionein-I and -II genes provides a reproductive advantage during maternal dietary zinc deficiency. J. Nutr., 1999, 129, 1643-1648.
51. Haq, F.; Mahoney, M.; Koropatnick, J. Signaling events for metallothionein induction. Mutat. Res.-Fundam. Mol. Mech. Mutagen., 2003, 533, 211-216.
52. Nordberg, G. F.; Garvey, J. S.; Chang, C. C. Metallothionein in plasma and urine of cadmium workers. Environ. Res., 1982, 28, 179-182.
53. Canpolat, E.; Lynes, M. A. In vivo manipulation of endogenous metallothionein with a monoclonal antibody enhances a T-dependent humoral immune response. Toxicol. Sci., 2001, 62, 61-70.
54. Lynes, M. A.; Borghesi, L. A.; Youn, J. H.; Olson, E. A. Immuno-modulatory activities of extracellular metallothionein 1: metallothionein effects on antibody-production. Toxicology, 1993, 85, 161-177.
55. Yin, X. Y.; Knecht, D. A.; Lynes, M. A. Metallothionein mediates leukocyte chemotaxis. BMC Immunol., 2005, 6, 12.
56. Abdel-Mageed, A. B.; Zhao, F. S.; Rider, B. J.; Agrawal, K. C. Erythropoietin-induced metallothionein gene expression: role in proliferation ofK562 cells. Exp. Biol. Med., 2003, 228, 1033-1039.
57. Karasawa, M.; Hosoi, J.; Hashiba, H.; Nose, K.; Tohyama, C.; Abe, E., Suda, T.; Kuroki, T. Regulation of metallothionein gene-expression by 1-Alpha,25-Dihydroxyvitamin-D3 in cultured-cells and in mice. Proc. Natl. Acad. Sci. USA, 1987, 84, 8810-8813.
58. Karin, M.; Imbra, R. J.; Heguy, A.; Wong, G. Interleukin-1 regulates human metallothionein gene-expression. Mol. Cell. Biol., 1985, 5, 2866-2869.
59. Nishimura, N.; Reeve, V. E.; Nishimura, H.; Satoh, M.; Tohyama, C. Cutaneous metallothionein induction by ultraviolet B irradiation in interleukin-6 null mice. J Invest. Dermatol., 2000, 114, 343-348.
60. Sato, M.; Sasaki, M.; Hajo, H. Tissue specific induction of metallothionein synthesis by tumor-necrosis-factor-alpha. Res. Commun. Chem. Path. Pharmacol., 1992, 75, 159-172.
61. Schroeder, J. J.; Cousins, R. J. Interleukin-6 regulates metallothionein gene-expression and zinc-metabolism in hepatocyte monolayer-cultures. Proc. Natl. Acad. Sci. USA, 1990, 87, 3137-3141.
62. Miyashita, H,; Sato, Y. Metallothionein 1 is a downstream target of vascular endothelial zinc finger I (VEZF1) in endothelial cells and participates in the regulation of angiogenesis. Endothelium, 2005, 12, 163-170.
63. Penkowa, M.; Keller, P.; Keller, C.; Hidalgo, J.; Giralt, M.; Pedersen, B. K. Exercise-induced metallothionein expression in human skeletal muscle fibres. Exp. Physiol., 2005, 90, 477-486.
64. Carrasco, J.; Giralt, M.; Penkowa, M.; Stalder, A. K.; Campbell, I. L.; Hidalgo, J. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha. Exp. Neurol., 2000, 163, 46-54.
65. Penkowa, M.; Carrasco, J.; Giralt, M.; Moos, T.; Hidalgo, J. CNS wound healing is severely depressed in metallothionein I and II-deficient mice. J. Neurosci., 1999, 19, 2535-2545.
66. Campagne, M. V.; Thibodeaux, H.; van Bruggen, N.; Cairns, B.; Gerlai, R.; Palmer, J. T.; Williams, S. P.; Lowe, D. G. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc. Natl. Acad. Sci. USA, 1999, 96, 12870-12875.
67. Giralt, M.; Penkowa, M.; Lago, N.; Molinero, A.; Hidalgo, J. Metallothionein-1+2 protect the CNS after a focal brain injury. Exp. Neurol., 2002, 173, 114-128.
68. Penkowa, M.; Florit, S.; Giralt, M.; Quintana, A.; Molinero, A.; Carrasco, J.; Hidalgo, J. Metallothionein reduces central nervous system inflammation, neuro degeneration, and cell death following kainic acid-induced epileptic seizures. J. Neurosci. Res., 2005, 79, 522-534.
69. Penkowa, M.; Giralt, M.; Camats, J.; Hidalgo, J. Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. J. Comp. Neurol., 2002, 444, 174-189.
70. Penkowa, M. Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J., 2006, 273, 1857-1870.
71. Chung, R. S.; Penkowa, M.; Dittmann, J.; King, C. E.; Bartlett, C.; Asmussen, J. W.; Hidalgo, J.; Carrasco, J.; Leung, Y. K.; Walker, A. K.; Fung, S. J.; Dunlop, S. A.; Fitzgerald, M.; Beazley, L. D.; Chuah, M. I.; Vickers, J. C.; West, A. K. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J. Biol. Chem., 2008, 283, 15349-15358.
72. Yu, W. H.; Lukiw, W. J.; Bergeronj C.; Niznik, H. B.; Fraser, P. E. Metallothionein III is reduced in Alzheimer's disease. Brain Res., 2001, 894, 37-45.
73. Jiang, P.; Chang, L.; Pan, C. S.; Qi, Y. F.; Tang, C. S. Protective role of metallothionein in stress-induced gastric ulcer in rats. World J. Gastroenterol., 2005, 11, 2739-2743.
74. Mita, M.; Satoh, M.; Shimada, A.; Okajima, M.; Azuma, S.; Suzuki, J. S.; Sakabe, K.; Hara, S.; Himeno, S. Metallothionein is a crucial protective factor against Helicobacter Pylori -induced gastric erosive lesions in a mouse model. Am. J. Physiol. Gastrointest. Liver Physiol., 2008.
75. Zhou, Z. X.; Sun, X. H.; Lambert, J. C.; Saari, J. T.; Kang, Y. J. Metallothionein-independent zinc protection from alcoholic liver injury. Am. J. Pathol., 2002, 160, 2267-2274.
76. Moffatt, P.; Denizeau, F. Metallothionein in physiological and physiopathological processes. Drug Metab. Rev., 1997, 29, 261-307.
77. Yoshida, M.; Ohta, H.; Yamauchi, Y.; Seki, Y.; Sagi, M.; Yamazaki, K.; Sumi, Y. Age-dependent changes in metallothionein levels in liver and kidney of the Japanese. Biol. Trace Elem. Res., 1998, 63, 167-175.
78. Onosaka, S.; Cherian, M. G. Comparison of metallothionein determination by polarographic and cadmium-saturation methods. Toxicol. Appl. Pharmacol., 1982, 63, 270-274.
79. Klein, D.; Sato, S.; Summer, K. H. Quantification of oxidized metallothionein in biological-material by a Cd saturation method. Anal. Biochem., 1994, 221, 405-409.
80. Hamilton, S. J.; Mehrle, P. M.; Jones, J. R. Cadmium-saturation technique for measuring metallothionein in brook trout. Trans. Am. Fish. Soc., 1987, 116, 541-550.
81. Dutton, M. D.; Stephenson, M.; Klaverkamp, J. F. A mercury saturation assay for measuring metallothionein in fish. Environ. Toxicol. Chem., 1993, 12, 1193-1202.
82. Scheuhammer, A. M.; Cherian, M. G. Quantification of metallothionein by silver saturation. Method Enzymol., 1991, 205, 78-83.
83. Klaverkamp, J. F.; Wautier, K.; Baron, C. L. A modified mercury saturation assay for measuring metallothionein. Aquat. Toxicol., 2000, 50, 13-25.
84. Szpunar, J. Advances in analytical methodology for bioinorganic speciation analysis: metallomics, metalloproteomics and heteroatom-tagged proteomics and metabolomics. Analyst, 2005, 130, 442-465.
85. Szpunar, J.; Lobinski, R.; Prange, A. Hyphenated techniques for elemental speciation in biological systems. Appl. Spectrosc., 2003, 57, 102A-112A.
86. Szpunar, J.; Lobinski, R. Multidimensional approaches in biochemical speciation analysis. Anal. Bioanal. Chem., 2002, 373, 404-411,
87. Polec-Pawlak, K.; Schaumloffel, D.; Szpunar, J.; Prange, A.; Lobinski, R. Analysis for metal complexes with metallothionein in rat liver by capillary zone electrophoresis using ICP doublefocussing sector-field isotope dilution MS and electrospray MS detection. J. Anal. At. Spectrom., 2002, 17, 908-912.
88. Polec, K.; Perez-Calvo, M.; Garcia-Arribas, O.; Szpunar, J.; RibasOzonas, B.; Lobinski, R. Investigation of metal complexes with metallothionein, in rat tissues by hyphenated techniques. J. Inorg. Biochem., 2002, 88, 197-206.
89. Polec, K.; Garcia-Arribas, O.; Perez-Calvo, M.; Szpunar, J.; RibasOzonas, B.; Lobinski, R. Identification of cadmium-bioinduced ligands in rat liver using parallel HPLC-ICP-MS and HPLCelectrospray MS. J. Anal. At. Spectrom., 2000, 15, 1363-1368.
90. Szpunar, J. Bio-inorganic speciation analysis by hyphenated techniques. Analyst., 2000, 125, 963-988.
91. Lobinski, R.; Chassaigne, H.; Szpunar, J. Analysis for metallothioneins using coupled techniques. Talanta, 1998, 46, 271-289.
92. Szpunar, J. Trace element speciation analysis of biomaterials by high-performance liquid chromatography with inductively coupled plasma mass spectrometric detection. Trac-Trends Anal. Chem., 2000, 19, 127-137.
93. Szpunar, J.; Lobinski, R. Species-selective analysis for metalbiomacromolecular complexes using hyphenated techniques. Pure Appl. Chem., 1999, 71, 899-918.
94. Schaumloffel, D.; Giusti, P.; Preud'Homme, H.; Szpunar, J.; Lobinski, R. Precolumn isotope dilution analysis in nanoHPLC-ICPMS for absolute quantification of sulfur-containing peptides. Anal. Chem., 2007, 79, 2859-2868.
95. Viarengo, A.; Ponzano, E.; Dondero, F.; Fabbri, R. A simple spectrophotometric method for metallothionein evaluation in marine organisms: an application to Mediterranean and Antarctic molluscs. Mar. Environ. Res., 1997, 44, 69-84.
96. Cotou, E.; Vagias, C.; Rapti, T.; Roussis, V. Metallothionein levels in the bivalves Callista chione and Venus verrucosa from two Mediterranean sites. Z.Naturforsch.(C), 2001, 56, 848-852.
97. Jiang, L. J.; Vasak, M.; Vallee, B. L.; Maret, W. Zinc transfer potentials of the alpha- and beta-clusters of metallothionein are affected by domain interactions in the whole molecule. Proc. Natl. Acad. Sci. USA, 2000, 97, 2503-2508.
98. 2+ release from metallothionein by destroying zincsulphur clusters without concomitant formation of S-nitrosothiol. Biochem. J., 1999, 344, 253-258.
99. Chu, M. M.; Guo, Z. Q.; Muto, N.; Itoh, N.; Tanaka, K.; Ren, H. W. Development of ELISA for metallothionein-II allows determination of heavy metal pollution of fresh water. Front. Biosci., 2006, 11, 2113-2122.
100. Alvarado, N. E.; Cancio, I.; Hylland, K.; Marigomez, I.; Soto, M. Immunolocalization of metallothioneins in different tissues of turbot (Scophdialmus maximus) exposed to Cd. Histol. Histopath., 2007, 22, 719-728.
101. Alves, S.; Cardoso, S. V.; Bernardes, V. D. F.; Machado, V. C.; Mesquita, R. A.; do Carmo, M. A. V.; Aguiar, M. C. F. Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands. Oral Oncol., 2007, 43, 252-256.
102. Saga, Y.; Hashimoto, H.; Yachiku, S.; Tokumitsu, M.; Kanekok S. hnmunohistochemical expression of metallothionein in human bladder cancer: correlation with histopathological parameters and patient survival. J. Urol., 2002, 168, 2227-2231.
103. Chassaigne, H.; Lobinski, R. Characterization of metallothionein isoforms by reversed-phase high-performance liquid chromatography with on-line post-colunin acidification and electrospray mass spectrometric detection. J. Chromatogr. A, 1998, 829, 127-136.
104. Chassaigne, H.; Lobinski, R. Characterization of horse kidney metallothionein isoforms by electrospray MS and reversed-phase HPLC-electrospray MS. Analyst, 1998, 123, 2125-2130.
105. Chassaigne, H.; Lobinski, R. Polymorphism and identification of metallothionein isoforms by reversed-phase HPLC with on-line ion spray mass spectrometric detection. Anal. Chem., 1998, 70, 2536-2543.
106. Nostelbacber, K.; Kirchgessner, M.; Stangl, G.I. Separation and quantitation of metallothionein isoforms from liver of untreated rats by ion-exchange high-performance liquid chromatography and atomic absorption spectrometry. J. Chromatogr. B, 2000, 744, 273-282.
107. Infante, H. G.; Van Campenhout, K.; Blust, R.; Adams, F. C. Anion-exchange high performance liquid chromatography hyphenated to inductively coupled plasma-isotope dilution-time-of-flight mass spectrometry for speciation analysis of metal complexes with metallothionein isoforms in gibel carp (Carassius auratus gibelio) exposed to environmental metal pollution. J. Chromatogr. A, 2006, 1121, 184-190.
108. Miyayama, T.; Ogra, Y.; Suzuki, K. T. Separation of metallothionein isoforms extracted from isoform-specific knockdown cells on two-dimensional micro high-performance liquid chromatography hyphenated with inductively coupled plasma-mass spectrometry. J. Anal. At. Spectrom., 2007, 22, 179-182.
109. Andon, B.; Barbosa, J.; Sanz-Nebot, V. Separation and characterization of rabbit liver apothioneins by capillary electrophoresis coupled to electrospray ionization time-of-flight mass spectrometry. Electrophoresis, 2006, 27, 3661-3670.
110. Baker, S. A.; Miller-Ihli, N. J. Comparison of a cross-flow and microconcentric nebulizer for chemical speciation measurements using CZE-ICP-MS. Appl. Spectrosc., 1999, 53, 471-478.
111. Haselberg, R.; de Jong, G. J.; Somsen, G. W. Capillary electrophoresis- mass spectrometry for the analysis of intact proteins. J. Chromatogr. A, 2007, 1159, 81-109.
112. Ohnesorge, J.; Neususs, C.; Watzig, H. Quantitation in capillary electrophoresis-mass spectrometry. Electrophoresis, 2005, 26, 3973-3987.
113. Wang, R. Y.; Sens, D. A.; Albrecht, A.; Garrett, S.; Somji, S.; Sens, M. A.; Lu, X. N. Simple method for identification of metallothionein isoforms in cultured human prostate cells by MALDITOF/TOF mass spectrometry. Anal. Chem., 2007, 79, 4433-4441.
114. Wilhelmsen, T. W.; Hansen, B. H.; Holten, V.; Olsvik, P. A.; Andersen, R. A. Improved separation of metallothionein isoforms by the presence of cyclodextrin in capillary zone electrophoresis. J. Chromatogr. A, 2004, 1051, 237-245.
115. Beattie, J. H.; Richards, M. P. Separation of metallothionein isoforms by micellar electrokinetic capillary chromatography. J. Chromatogr. A, 1994, 664, 129-134.
116. Beattie, J. H. Strategies for the qualitative and quantitative analysis of metallothionein isoforms by capillary electrophoresis. Talanta, 1998, 46, 255-270.
117. Virtanen, V.; Bordin, G.; Rodriguez, A. R. Separation of metallothionein isoforms with capillary zone electrophoresis using an uncoated capillary column - effects of pH, temperature, voltage, buffer concentration and buffer composition. J. Chromatogr. A, 1996, 734, 391-400.
118. Minami, T.; Ichida, S.; Kubo, K. Study of metallothionein using capillary zone electrophoresis. J. Chromatogr. B, 2002, 781, 303-311.
119. Minami, T.; Kubo, K.; Ichida, S. Determination of metallothionein1/ metallothionein-2 ratios in the mouse liver and pancreas by capillary zone electrophoresis using a polyacrylamide-coated capillary at neutral pH. J. Chromatogr. B, 2002, 779, 211-219.
120. Minami, T.; Tolmo, Y.; Okazaki, Y.; Kubo, K.; Otaki, N.; Kimura, M. Quantitation of metallothionein isoforms in mouse liver on capillary zone electrophoresis. Anal. Chim. Acta., 1998, 372, 241-247.
121. Sonke, J. E.; Salters, V. J. M. Capillary electrophoresis-high resolution sector field inductively coupled plasma mass spectrometry. J. Chromatogr. A, 2007, 1159, 63-74.
122. Ganguly, S.; Taioli, E.; Baranski, B.; Cohen, B.; Toniolo, P.; Garte, S. J. Human metallothionein gene expression determined by quantitative reverse transcription-polymerase chain reaction as a biomarker of cadmium exposure. Cancer Epidemiol. Biomarkers Prev., 1996, 5, 297-301.
123. Choi, C. Y.; An, K. W.; Nelson, E. R.; Habibi, H. R. Cadmium affects the expression of metallothionein (MT) and glutathione peroxidase (GPX) mRNA in goldfish, Carassius auratus. Comp. Biochem. Physiol. C-Taxicol. Pharmacol., 2007, 145, 595-600.
124. Ono, S. I.; Ishizaki, Y.; Tokuda, E. I.; Tabata, K. I.; Asami, S.; Suzuki, T. Different patterns in the induction of metallothionein mRNA synthesis among isoforms after acute ethanol administration. Biol. Trace Elem. Res., 2007, 115, 147-156.
125. Kwon, C. S.; Kountouri, A. M.; Mayer, C.; Gordon, M. J.; Kwun, I.S.; Beattie, J. H. Mononuclear cell metallothionein mRNA levels in human subjects with poor zinc nutrition. Br. J. Nutr., 2007, 97, 247-254.
126. Timmermans, M.; Ellers, J.; Roelofs, D.; Van Straalen, N. M. Metallothionein mRNA expression and cadmium tolerance in metal-stressed and reference populations of the springtail Orchesella, cincta. Ecotoxicology, 2005, 14, 727-739.
127. Shanker, A. K.; Djanaguiraman, M.; Sudhagar, R.; Jayaram, K.; Pathmanabhan, G. Expression of metallothionein 3-like protein mRNA in sorghum cultivars under chromium(VI) stress. Curr. Sci., 2004, 86, 901-902.
128. Vasconcelos, M. H.; Tam, S. C.; Hesketh, J. E.; Reid, M.; Beattie, J. H. Metal- and tissue-dependent relationship between metallothionein mRNA and protein. Toxicol. Appl. Pharmacol., 2002, 182, 91-97.
129. Harlyk, C.; Bordin, G.; Nieto, O.; Rodriguez, A. R. Electrochemical behaviour of a metallothionein related peptide in the presence of cadmium using cyclic voltammetry. J. Electroanal. Chem., 1998, 446, 139-150.
130. Harlyk, C.; Nieto, O.; Bordin, G.; Rodriguez, A. R. Electrochemical study of metallothioneins using cyclic voltammetry. J. Electroanal. Chem., 1998, 458, 199-208.
131. Harlyk, C.; Nieto, O.; Bordin, G.; Rodriguez, A. R. Electrochemical study of a metallothionein related peptide in the presence of zinc using cyclic voltammetry. J. Electroanal. Chem., 1998, 451, 267-272.
132. Dabrio, M.; Rodriguez, A. R.; Bordin, G.; Bebianno, M. J.; De Ley, M.; Šestakova, I.; Vasak, M.; Nordberg, M. Recent developments. in quantification methods for metallothionein. J. Inorg. Biochem., 2002, 88, 123-134.
133. Petrlova, J.; Potesil, D.; Mikelova, R.; Blastik, O.; Adam, V.; Trnkova, L.; Jelen, F.; Prusa, R.; Kukacka, J.; Kizek, R. Attomole voltammetric determination of metallothionein. Electrochim. Acta, 2006, 51, 5112-5119.
134. Adam, V.; Petrlova, J.; Potesil, D.; Zehnalek, J.; Sures, B.; Trnkova, L.; Jelen, F.; Kizek, R. Study of metallothionein modified electrode surface behaviour in the presence of heavy metal ions - biosensor. Electroanalysis, 2005, 17, 1649-1657.
135. Dabrio, M.; Rodriguez, A. R. Characterisation of zinc metallothioneins by electreanalytical techniques. Anal. Chim. Acta, 1999, 385, 295-306.
136. Dabrio, M.; Rodriguez, A. R. Electrochemical study of human foetal liver metallothionein: influence of the additions of cadmium and zinc. Anal. Chim. Acta., 2000, 406, 171-181.
137. Dabrio, M.; Rodriguez, A. R. Study of complexing properties of the α-metallothionein domain with cadmium and/or zinc, using differential pulse polarography. Anal. Chim. Acta., 2000, 424, 77-90.
138. Dabrio, M.; Rodriguez, A. R. Complexing properties of the beta metallothionein domain with cadmium and/or zinc, studied by differential pulse polarography. Analysis, 2000, 28, 370-381.
139. Dabrio, M.; Rodriguez, A. R. study of zinc metallothionein from rat liver using electrochemical techniques. Electroanalysis, 2000, 12, 1026-1033.
140. Erk, M.; Ivankoviç, D.; Raspor, B.; Paviciç, J. Evaluation of different purification procedures for the electrochemical quantification of mussel metallothioneins. Talantar, 2002, 57, 1211-1218.
141. Erk, M.; Raspor, B. Evaluation of cadmiurn-metallothionein stability constants based on voltammetric measurement. Anal. Chim. Acta., 1998, 360, 189-194.
142. Erk, M.; Raspor, B. Advantages and disadvantages of voltammetric method in studying cadmium-metallothionein interactions. Cell. Mol. Biol., 2000, 46, 269-281.
143. Ivankovic, D.; Pavicic, J.; Raspor, B.; Falnoga, I.; Tusek-Znidaric, T. Comparison of two SH-based methods for estimation of metallothionein level in the digestive gland of naturally occurring mussels, Mytilus galloprovincialis. Int. J. Environ. Anal. Chem., 2003, 83, 219-231.
144. Limson, J.; Nyokong, T. Voltammetric behavior of cysteine and metallothionein on cobalt(II) tetrasulfonated phthalocyanine modified glassy carbon electrodes. Electroanalysis, 1997, 9, 255-260.
145. Olafson, R. W.; Sim, R. G. Electrochemical approach to quantitation and characterization of metallothioneins. Anal. Biochem., 1979, 100, 343-351.
146. Raspor, B.; Paic, M.; Erk, M. Analysis of metallothioneins by the modified Brdicka procedure. Talanta, 2001, 55, 109-115.
147. Sestakova, I.; Navratil, T. Voltammetric methods in metallothionein research. Bioinorg. Chem. Appl., 2005, 3, 43-53.
148. Yang, J.; Cao, Y.; Yang, M. S. Determination of metallotionein content in hepatoma cells by differential pulse polarography. Chem.-Biol. Interact., 1998, 114, 109-116.
149. Kukacka, J.; Vajtr, D.; Huska, D.; Prusa, R.; Houstava, L.; Samal, F.; Diopan, V.; Kotaska, K.; Kizek, R. Blood metallothionein, neuron specific enolase, and protein S100B in patients with traumatic brain injury. Neuroendocrinol. Lett., 2006, 27, 116-120.
150. Adam, V.; Krizkova, S.; Zitka, O.; Trnkova, L.; Petrlova, J.; Beklova, M.; Kizek, R. Determination of apo-metallothionein using adsorptive transfer stripping technique in connection with differential pulse voltammetry. Electroanalysis, 2007, 19, 339-347.
151. Xu, M. T.; Wu, Y. H.; Wang, J. X.; Zhou, F. M. Electrochemistry of and redox-induced metal release from metallothioneins at a nafion-coated bismuth film electrode. Electroanalysis, 2006, 18, 2099-2105.
152. Kizek, R.; Trnkova, L.; Palecek, E. Determination of metallothionein at the femtomole level by constant current stripping chronopotentiometry. Anal. Chem., 2001, 73, 4801-4807.
153. Kizek, R.; Vacek, J.; Trnkova, L.; Klejdus, B.; Havel, L. Application of catalytic reactions on a mercury electrode for electrochemical detection of metallothioneins. Chem. Listy, 2004, 98, 166-173.
154. Prusa, R.; Blastik, O.; Potesil, D.; Trnkova, L.; Zehnalek, J.; Adam, V.; Petrlova, J.; Jelen, F.; Kizek, R. Analytic method for determination of metallothioneins as tumor markers. Clin. Chem., 2005, 51, A56-A56.
155. Prusa, R.; Kizek, R.; Trnkova, L.; Vacek J.; Zehnalek, J. Study of relationship between metallothionein and heavy metals by CPSA method. Clin. Chem., 2004, 50, A28-A29.
156. Strouhal, M.; Kizek, R.; Vecek, J.; Trnkova, L.; Nemec, M. Electrochemical study of heavy metals and metallothionein in yeast Yarrowia lipolytica. Bioelectrochemistry, 2003, 60, 29-36.
157. Trnkova, L.; Kizek, R.; Vacek, J. Catalytic signal of rabbit liver metallothionein on a mercury electrode: a combination of derivative chronopotentiometry with adsorptive transfer stripping. Bioelectrochemistry, 2002, 56, 57-61.
158. Sestakova, I.; Kopanica, M.; Havran, L.; Palecek, E. Constant current chronopotentiometric stripping analysis of Cd-metallothionein on carbon and mercury electrodes. Comparison with voltammetry. Electroanalysis, 2000, 12, 100-104.
159. Krizkova, S.; Zitka, O.; Adam, V.; Beklova, M.; Horna, A.; Svobodova, Z.; Sures, B.; Trnkova, L.; Zeman, L., Kizek, R. Possibilities of electrochemical techniques in metallothionein and lead detection in fish tissues. Czech J. Anim. Sci., 2007, 52, 143-148.
160. Serrano, N.; Sestakova, I.; Diaz-Cruz, J. M.; Arino, C. Adsorptive accumulation in constant current stripping chronopotentiometry as an alternative for the electrochemical study of metal complexation by thiol-containing peptides. J. Electroanal. Chem., 2006, 591, 105-117.
161. Serrano, N.; Sestakova, I.; Diaz-Cruz, J. M. Constant current stripping chronopotentiometry for the study of adsorbing inert and electrochemically nonreversible metal complexes at low concentrations: application to Cd and Zn metallothioneins. Electroanalysis, 2006, 18, 169-176.
162. El Hourch, M.; Dudoit, A.; Amiard, J. C. An optimization procedure for determination of metallothionein by square wave cathodic stripping voltammetry: application to marine worms. Anal. Bioanal. Chem., 2004, 378, 776-781.
163. Esteban, M.; Harlyk, C.; Rodriguez, A. R. Cadmium binding properties of the C-terminal hexapeptide from mouse metallothionein: study by linear sweep voltammetry and multivariate curve resolution analysis. J. Electroanal. Chem., 1999, 468, 202-212.
164. Mendieta, J.; Diaz-Cruz, M. S.; Monjonell, A.; Tauler, R.; Esteban, M. Complexation of cadmium by the C-terminal hexapeptide Lys-Cys-Thr-Cys-Cys-Ala from mouse metallothionein: study by differential pulse polarography and circular dichroism spectroscopy with multivariate curve resolution analysis. Anal. Chim. Acta., 1999, 390, 15-25.
165. Scarano, G.; Morelli, E. Cathodic stripping voltammetric determination of metallothioneins. Electroanalysis, 1996, 8, 396-398.
166. Tomschik, M.; Havran, L.; Palecek, E.; Heyrovsky, M. The "presodium" catalysis of electroreduction of hydrogen ions on mercury electrodes by metallothionein: an investigation by constant current derivative stripping chronopotentiometry. Electroanalysis, 2000, 12, 274-279.
167. Tomschik, M.; Havran, L.; Fojta, M.; Palecek, E. Constant current chronopotentiometric stripping analysis of bioactive peptides at mercury and carbon electrodes. Electroanalysis, 1998, 10, 403-409.
168. Adam, V.; Kizek, R. Utilizing of Electrochemical and Bioanalytical Methods in Biological Research, Research Signpost: Kerala, India, 2007.
169. Palecek, E.; Postbieglova, I. Adsorptive Stripping Voltammetry of Biomacromolecules with Transfer of the Adsorbed Layer. J. Electroanal. Chem., 1986, 214, 359-371.
170. Raspor, B. Elucidation of the mechanism of the Brdicka reaction. J. Electroanal. Chem., 2001, 503, 159-162.
171. Krizkova, S.; Fabrik, I.; Adam, V.; Kukacka, J.; Prusa, R,; Trnkova, L.; Strnadel, J.; Horak, V.; Kizek, R. Optimization of adsorptive transfer stripping technique for determination of metallothioneins level in melanoma cells, blood serum and tissues. Sensors, 2008, 8, 3106-3122.
172. Dziegiel, P.; Jelen, M.; Muszczynska, B.; Maciejczyk, A.; Szulc, A.; Podhorska-Okolow, M.; Cegielski, M.; Zabel, M. Role of metallothionein expression in non-small cell lung carcinomas. Roczniki Akademii Medycznej w Bialymstoku, 2004, 49, 43-45.
173. Goldmann, T.; Ribbert, D.; Suter, L.; Brode, M.; Otto, F. Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics. J. Exp. Clin. Cancer Res., 1998, 17, 483-489.
174. Jin, R. X.; Huang, J. X.; Tan, P. H.; Bay, B. H. Clinicopathological significance of metallothioneins in breast cancer. Pathol. Oncol. Res., 2004, 10, 74-79.
175. Mitropoulos, D.; Kyroudi-Voulgari, A.; Theocharis, S.; Serafetinides, E.; Moraitis, E.; Zervas, A.; Kittas, C. Prognostic significance of metallothionein expression in renal cell carcinoma. World J. Gastroenterol., 2005, 3, 5.
176. Ohshio, G.; Imamura, T.; Okada, N.; Wang, Z. H.; Yamaki, K.; Kyogoku, T.; Suwa, H.; Yamabe, H.; Imamura, M. Immunohistochemical study of metallothionein in pancreatic carcinomas. J. Cancer Res. Clin. Oncol., 1996, 122, 351-355.
177. Rossen, K.; Haerslev, T.; HouJensen, K.; Jacobsen, G. K. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas. AP MIS, 1997, 105, 35-40.
178. Sauerbrey, A.; Zintl, F.; Volm, M. Expression of metallothionein in initial and relapsed childhood acute lymphoblastic-leukemia. Ann. Hematol., 1994, 69, 111-115.
179. Shukla, V. K.; Aryya, N. C.; Pitale, A.; Pandey, M.; Dixit, V. K.; Reddy, C. D.; Gautam, A. Metallothionein expression in carcinoma of the gallbladder. Histopathology, 1998, 33, 154-157.
180. Sugita, K.; Yamamoto, O.; Asahi, M. Immunohistochemical analysis of metallothionein expression in malignant melanoma in Japanese patients. Am. J. Dermatopathol., 2001, 23, 29-35.
181. Surowiak, P.; Materna, V.; Kaplenko, I.; Spaczynski, M.; Dietel, M.; Lage, H.; Zabel, M. Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients. Virchows Arch., 2005, 447, 626-633.
182. Zelger, B.; Hittmair, A.; Schir, M.; Ofner, C.; Ofner, D.; Fritsch, P. O.; Bocker, W.; Jasani, B.; Schmid, K. W. Immunohistochemically demonstrated metallothionein expression in malignant-melanoma. Histopathology, 1993, 23, 257-264.
183. Adam, V.; Blastik, O.; Krizkova, S.; Lubal, P.; Kukacka, J.; Prusa, R.; Kizek, R. Using of Brdicka reaction for determination of metallothionein at patients with tumor diseases. Chem. Listy, 2007, 102, 51-58.
184. Petrlova, J.; Blastik, O.; Prusa, R.; Kukacka, J.; Mikelova, R.; Stiborova, M.; Adam, V.; Zitka, O.; Eckschlager, T.; Kizek, R. Determination of metallothionein content in patients with breast and colon cancer, and malignant melanoma. Klin. Onkol., 2006, 19, 138-142.
185. Jasani, B.; Schmid, K. W. Significance of metallothionein overexpression in human. Histopathology, 1997, 31, 211-214.
186. Ofner, D.; Maier, H.; Riedmann, B.; Bammer, T.; Rumer, A.; Winde, G.; Bocker, W.; Jasani, B.; Schmid, K. W. Immunohistochemical metallothionein expression in colorectal adenocarcinoma correlation with tumor stage and patient survival. Virchows Arch. Int. J. Pathol., 1994, 425, 491-497.
187. Cherian, M. G.; Jayasurya, A.; Bay, B. H. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat. Res.-Fundam. Mol. Mech. Mutagen., 2003, 533, 201-209.
188. Theocharis, S. E.; Margeli, A. P.; Klijanienko, J. T.; Kouraklis, G. P. Metallothionein expression in human neoplasia. Histopathology, 2004, 45, 103-118.
189. Lowndes, S. A.; Harris, A. L. The role of copper in tumor angiogenesis. J. Mammary Gland Biol. Neoplasia, 2005, 10, 299-310.
190. Bier, B.; Douglasjones, A.; Totsch, M.; Dockhorndworniczak, B.; Bocker, W.; Jasani, B.; Schmid, K. W. Immunchistochemical demonstration of metallothionein in normal human breast-tissue and benign and malignant breast-lesions. Breast Cancer Res. Treat., 1994, 30, 213-221.
191. Zhang, R.; Zhang, H.; Wei, H.; Luo, X. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. J. Environ. Pathol. Toxicol. Oncol., 2000, 19, 95-97.
192. Sens, M. A.; Somji, S.; Lamm, D. L.; Garrett, S. H.; Slovinsky, F.; Todd, J. H.; Sens, D. A. Metallothionein isoform 3 as a potential biomarker for human bladder cancer. Environ. Health Perspect., 2000, 108, 413-418.
193. Jin, R. X.; Bay, B. H.; Chow, V. T. K.; Tan, P. H. Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma. Breast Cancer Res. Treat., 2001, 66, 265-272.
194. Bay, B. H.; Jin, R. X.; Huang, J. X.; Tan, P. H. Metallothionein as a prognostic biomarker in breast cancer. Exp. Biol. Med., 2006, 231, 1516-1521.
195. Surowiak, P.; Materna, V.; Gyorffy, B.; Matkowski, R.; Wojnar, A.; Maciejczyk, A.; Paluchowski, P.; Dziegiel, P.; Pudelko, M.; Kornafel, J.; Dietel, M.; Kristiansen, G.; Zabel, M.; Lage, H. Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. Br. J. Cancer, 2006, 95, 3 39-346.
196. Haerslev, T.; Jacobsen, G. K.; Zedeler, K. The prognostic-significance of immunohistochemically detectable metallothionein in primary breast carcinomas. APMIS, 1995, 103, 279-285.
197. Vaquez-Ramirez, F. J.; Gonzalez-Campora, J. J.; Hevia-Alvarez, E.; Fernandez-Santos, J. M.; Rios-Martin, J. J.; Otal-Salaverri, C.; Gonzalez-Campora, R. P-glycoprotein, metallothionein and NM23 protein expressions in breast carcinoma. Pathol. Res. Pract., 2000, 196, 553-559.
198. Garrett, S. H.; Sens, M. A.; Shukla, D.; Flores, L.; Somji, S.; Todd, J. H.; Sens, D. A. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-IX in advanced prostate cancer. Prostate, 2000, 43, 125-135.
199. Athanassiadou, P.; Bantis, A.; Gonidi, M.; Athanassiades, P.; Agelonidou, E.; Grapsa, D.; Nikolopoulou, P.; Patsouris, E. The expression of metallothioneins on imprint smears of prostate carcinoma: correlation with clinicopathologic parameters and tumor proliferative capacity. Tumor, 2007, 93, 189-194.
200. McCluggage, W. G.; Strand, K.; Abdulkadir, A. Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors. Int. J. Gynecol. Cancer, 2002, 12, 62-65.
201. Zagorianakou, N.; Stefanou, D.; Makrydimas, G.; Zagorianakou, P.; Briasoulis, E.; Karavasihs, V.; Pavlidis, N.; Agnantis, N. J. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors. Histol. Histopath., 2006, 21, 341-347.
202. Hengstler, J. G.; Pilch, H.; Schmidt, M.; Dahlenburg, H.; Sagemuller, J.; Schiffer, I.; Oesch, F.; Knapstein, P. G.; Kaina, B.; Tanner, B. Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis. Int. J. Cancer, 2001, 95, 121-127.
203. Ioachim, E. E.; Kitsiou, E.; Carassavoglou, C.; Stefanaki, S.; Agnantis, N. J. Immunohistochemical localization of metallothionein in endometrial lesions. J. Pathol., 2000, 191, 269-273.
204. Cardoso, S. V.; Barbosa, H. M.; Candellori, I. M.; Loyola, A. M.; Aguiar, M. C. F. Prognostic impact of metallothionein on oral squamous cell carcinoma. Virchows Arch., 2002, 441, 174-178.
205. Johann, A.C.; da Silveira-Junior, J.B.; Souto, G.R.; Horta, M.C.; Aguiar, M.C.; Mesquita, R.A. Metallothionein immunoexpression in oral leukoplakia. Med. Oral Patol. Oral Cir. Bucal., 2008, 13, E156-E160.
206. Pastuszewski, W.; Dziegiel, P.; Krecicki, T.; Podhorska-Okolow, M.; Ciesielska, U.; Gorzynska, E.; Zabel, M. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res., 2007, 27, 335-342.
207. Theocharis, S.; Karkantaris, C.; Philipides, T.; Agapitos, E.; Gika, A.; Margeli, A.; Kittas, C.; Koutselinis, A. Expression of metallothionein in lung carcinoma: correlation with histological type and. Histopathology, 2002, 40, 143-151.
208. Joseph, M. G.; Banerjee, D.; Kocha, W.; Feld, R.; Stitt, L. W.; Cherian, M. G. Metallothionein expression in patients with small cell carcinoma of the lung - Correlation with other molecular markers and clinical outcome. Cancer, 2001, 92, 836-842.
209. Isik, R.; Metintas, M.; Gibbs, A. R.; Metintas, S.; Jasani, B.; Oner, U.; Harmanci, E.; Demircan, S.; Isiksoy, S. p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure. Respir. Med., 2001, 95, 588-593.
210. Zhang, X. H.; Takenaka, I. Incidence of apoptosis and metallothionein expression in renal cell carcinoma. Br. J. Urol., 1998, 81, 9-13.
211. Ioachim, E. E.; Charchanti, A. V.; Stavropoulos, N. E.; Athanassiou, E. D.; Michael, M. C.; Agnantis, N. J. Localization of metallothionein in urothelial carcinoma of the human urinary bladder: An immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices. Anticancer Res., 2001, 21, 1757-1761.
212. Yamasaki, Y.; Smith, C.; Weisz, D.; van Ruizen, I.; Xuan, J.; Moussa, M.; Stitt, L.; Hideki, S.; Cherian, M. G.; Izawa, J. I. Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder. Urology, 2006, 67, 530-535.
213. Smith, E.; Drew, P. A.; Tian, Z. Q.; De Young, N. J.; Liu, J. F.; Mayne, G. C.; Ruszkiewicz, A. R.; Watson, D. I.; Jamieson, G. G. Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol. Cancer, 2005, 4, 9.
214. Li, Y.; Wo, J. M.; Cai, L.; Zhou, Z. X.; Rosenbaum, D.; Mendez, C.; Ray, M. B.; Jones, W. F.; Kang, Y. J. Association of metallothionein expression and lack of apoptosis with progression of carcinogenesis in Barrett's esophagus. Exp. Biol. Med., 2003, 228, 286-292.
215. Ebert, M. P. A.; Gunther, T.; Hoffmann, J.; Yu, J.; Miehlke, S.; Schulz, H. U.; Roessner, A.; Korc, M.; Malfertheiner, P. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res., 2000, 60, 1995-2001.
216. Galizia, G.; Ferraraccio, F.; Lieto, E.; Orditura, M.; Castellano, P.; Imperatore, V.; La Manna, G.; Pinto, M.; Ciardiello, F.; La Mura, A.; De Vita, F. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate. J. Surg. Oncol., 2006, 93, 241-252.
217. Mitani, T.; Shirasaka, D.; Aoyama, N.; Miki, I.; Morita, Y.; Ikehara, N.; Matsumoto, Y.; Okuno, T.; Toyoda, M.; Miyachi, H.; Yoshida, S.; Chayahara, N.; Hori, J.; Tamura, T.; Azuma, T.; Kasuga, M. Role of metallothionein in Helicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy. J. Gastroenterol. Hepatol., 2007, doi: 10.11111/j.1440-1746.2007.05124.x.
218. Hishikawa, Y.; Kohno, H.; Ueda, S.; Kimoto, T.; Dhar, D. K.; Kubota, H.; Tachibana, M.; Koji, T.; Nagasue, N. Expression of metallothionein in colorectal cancers and synchronous liver metastases. Oncology, 2001, 61, 162-167.
219. Janssen, A. M. L.; van Duijn, W.; Kubben, F.; Griffioen, G.; Lamers, C.; van Krieken, J.; van de Velde, C. J. H.; Verspaget, H. W. Prognostic significance of metallothionein in human gastrointestinal cancer. Clin. Cancer Res., 2002, 8, 1889-1896.
220. Weinlich, G.; Eisendle, K.; Hassler, E.; Baltaci, M.; Fritsch, P. O.; Zelger, B. Metallothionem - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. Br. J. Cancer, 2006, 94, 835-841.
221. Poulsen, C. B.; Borup, R.; Borregaard, N.; Nielsen, F. C.; Moller, M. B.; Ralfkiaer, E. Prognostic significance of metallothionein in B-cell lymphomas. Blood, 2006, 108, 3514-3519.
222. Dziegiel, P.; Salwa-Zurawska, W.; Zurawski, J.; Wojnar, A.; Zabel, M. Prognostic significance of augmented metallothionein (MT) expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas. Histol. Histopath., 2005, 20, 83-89.
223. Dziegiel, P.; Suder, E.; Surowiak, P.; Kornafel, J.; Zabel, M. Expression of metallothionein in synovial sarcoma cells. Appl. Immunohistochem., 2002, 10, 357-362.
224. Bedmicek, J.; Vicha, A.; Jarosova, M.; Holzerova, M.; Cinatl, J.; Michaelis, M.; Cinatl, J.; Eckschlager, T. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization. Neoplasma, 2005, 52, 415-419.
225. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer, 2007, 7, 573-584.
226. Andrews, P. A.; Murphy, M. P.; Howell, S. B. Metallothionein-mediated cisplatin resistance in human ovarian-carcinoma cells. Cancer Chemother. Pharmacol., 1987, 19, 149-154.
227. Choi, C. H.; Cha, Y. J.; An, C. S.; Kim, K. J.; Kim, K. C.; Moon, S. P.; Lee, Z. H.; Min, Y. D. Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein. Canc. Cell Int., 2004, 4, 6.
228. Liang, X.; Huang, Y. Intracellular free calcium concentration and cisplatin resistance in human lung adenocarcinoma A549 cells. Biosci. Rep., 2000, 20, 129-138.
229. Surowiak, P.; Materna, V.; Maciejczyk, A.; Pudelko, M.; Markwitz, E.; Spaczynski, M.; Dietel, M.; Zabel, M.; Lage, H. Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome. Virchows Arch., 2007, 450, 279-285.
230. Shimoda, R.; Achanzar, W. E., Qu, W.; Nagamine, T.; Takagi, H.; Mori, M.; Waalkes, M. P. Metallothionein is a potential negative regulator of apoptosis. Toxicol. Sci., 2003, 73, 294-300.
231. Chun, J. H.; Kim, H. K.; Kim, E.; Kim, I. H.; Kim, J. H.; Chang, H. J.; Choi, I. J.; Lim, H. S.; Kim, I. J.; Kang, H. C.; Park, J. H.; Bae, J. M.; Park, J. G. Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer. Cancer Res., 2004, 64, 4703-4706.
232. Bacolod, M. D.; Johnson, S. P.; Ali-Osman, F.; Modrich, P.; Bullock, N. S.; Colvin, O. M.; Bigner, D. D.; Friedman, H. S. Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma. Mol. Cancer Ther., 2002, 1, 727-736.
233. Sun, X. H.; Kang, Y. J. Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity. Exp. Biol. Med., 2002, 227, 652-657.
234. Kang, Y. J. Antioxidant defense against anthracycline cardiotoxicity by metallothionein. Cardiovasc. Toxicol., 2007, 7, 95-100.
235. Schafer, F. Q.; Buettner, G. R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med., 2001, 30, 1191-1212.